Hello,
Today in
Plus: Kimberly Leonard has a comprehensive look at everything that could go wrong in a coronavirus-vaccine handoff if Biden ousts Trump in November.
And a lil' news from me: Healthcare startup Bind, known for its on-demand plans, is getting into the insurance business, starting with fully-insured employers in Florida. It has its eyes on the individual exchanges next.
Drugmakers still haven't started testing their coronavirus vaccines in children, putting kids at the end of the line for a potential shot
- Ongoing clinical trials are testing the top
coronavirus vaccine candidates only in adults. - Some experts are worried about the timeline for making a shot available to kids.
- Moderna expects to start testing its vaccine candidate in kids later this year, if regulators give the Massachusetts biotech the greenlight, Business Insider has learned.
Read the full story from Andrew Dunn here>>
Discount prescription drug startup GoodRx surged 53% in its first day of trading. Here's what you need to know.
GoodRx , a discount-prescription startup, went public on Wednesday at $33 per share and surged to close at $50.50.- The stock closed with a market cap of $19.4 billion.
- GoodRx has been profitable since 2016, according to the filing, making it an outlier among its recently public peers and an appealing investment for public-market traders.
Read the full recap of GoodRx's first day of trading from Megan Hernbroth here>>
How a 38-year-old who taught himself health technology is shaping a key part of Amazon's plans to transform healthcare
Amazon Care , the company'shealth clinic, is expanding to cover all Washington employees.- Business Insider spoke with one of its tech leaders, Erik Cardenas, about
Amazon Care's strategy. - The 38-year-old self-taught leader is trying to coordinate employees' results, appointments, and histories into a seamless system.
Read the full story from Blake Dodge here>>
More stories we're reading:
- 2 top execs at Microsoft lay out how it's using the cloud to take on Google and Amazon as tech giants push deeper into the $3.6 trillion healthcare industry (Business Insider)
- The UK is expecting to run trials in January testing vaccines on volunteers that have been intentionally infected with COVID-19 (Financial Times)
- GoodRx's co-CEOs made millions when the company went public. Here's how their compensation compares to leaders at CVS, Walgreens, and Teladoc.(Business Insider)
- Demand for lab space is booming, and real-estate giant JLL just hired a new life-sciences expert to lean into the opportunity (Business Insider)
- Reopening colleges likely fueled COVID-19, according to a study (The Wall Street Journal)
I'll be back with a weekly wrap-up of healthcare news tomorrow (what a week!) See you then.
Don't forget to subscribe to our newsletter here!
- Lydia